Curative treatment of peritoneal carcinomatosis of colorectal origin
Up to 8% of all patients with colorectal cancer have peritoneal carcinomatosis (PC) as the only site of disease at some point in time. Traditional treatment by limited palliative surgery and systemic chemotherapy has poor results with few patients surviving longer than 3 years. Complete cytoreductive surgery combined with Hyperthermic Intra Peritoneal Chemotherapy (HIPEC), using Mitomycin C, follo